glp 1 resistance GLP-1 agonists in pediatric obesity: an integrative perspective on cell signaling, development Frontiers | Future Perspectives on
Description
52225232, Nov
Efficacy of lifestyle modification combined with GLP-1 receptor agonists on body weight and cardiometabolic biomarkers in individuals with overweight or obesity: A systematic review and meta-analysis
Do GLP-1 medications lose effectiveness over time
95% CI, 0.10-0.34
Daniel Drucker, a GLP-1 researcher
